Study Stopped
Company shifted focus
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
1 other identifier
observational
N/A
1 country
1
Brief Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2019
CompletedFirst Posted
Study publicly available on registry
December 26, 2019
CompletedStudy Start
First participant enrolled
March 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2030
June 5, 2025
June 1, 2025
10 years
December 23, 2019
June 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with bipolar disorder
Three years
Study Arms (1)
Bipolar Disorder
Patients with bipolar disorder
Interventions
Eligibility Criteria
Patients diagnosed with bipolar disorder
You may qualify if:
- Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
- a. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
- Male or female of all ages.
- Greater than seven endorsements on the bipolar disorder questionnaire.
You may not qualify if:
- Refusal to sign informed consent form
- History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
- Postoperative stoma, ostomy, or ileoanal pouch
- Participation in any experimental drug protocol within the past 12 weeks
- Treatment with total parenteral nutrition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ProgenaBiomelead
Study Sites (1)
ProgenaBiome
Ventura, California, 93003, United States
Biospecimen
Stool samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabine Hazan, MD
ProgenaBiome
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2019
First Posted
December 26, 2019
Study Start
March 2, 2020
Primary Completion (Estimated)
March 1, 2030
Study Completion (Estimated)
July 1, 2030
Last Updated
June 5, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD.